ArticleBrain, behavior, & immunity - health2026
The role of oral contraceptive use in associations of concussion history with kynurenine pathway metabolites, inflammation, and psychological symptoms in female athletes.
Article in Brain, behavior, & immunity - health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Concussion history is linked to increased risk of psychological symptoms, potentially through inflammation-driven activation of the kynurenine pathway (KP). Use of oral contraceptives (OC) is also associated with increased inflammation, reduced protective kynurenic acid (KynA), and, in some cases, increased psychological symptoms. Despite this evidence and the fact that around half of all female collegiate athletes use OCs, existing research in this area does not account for OC use among female athletes. In this study, we tested the hypothesis that OC use moderates the association of number of prior concussions with serum inflammatory markers and KP metabolites and self-reported psychological symptoms. Collegiate female athletes (N = 69; 30 using OC) participating in a larger cross-sectional study completed semi-structured interviews to retrospectively determine the number of prior concussions (last injury at least 6 months before study enrollment). Linear models assessed associations between the number of prior concussions, OC use, and their interaction with outcomes, controlling for contact-sport exposure. Split analyses tested these associations in athletes using OC versus those not using hormonal contraception (NoHC). Additional exploratory linear models assessed associations between the number of prior concussions, hormonal activity levels of OC, and their interaction on outcomes, controlling for contact-sport exposure. Higher number of prior concussions was associated with elevated quinolinic acid (QuinA), interleukin (IL)-1 receptor antagonist, and psychological symptoms. Although there was no significant interaction, split analyses showed these relationships held only in the NoHC group. Moreover, compared to the NoHC group, OC users exhibited higher C-reactive protein and IL-6 and lower KynA, KynA/QuinA, and KynA/3-hydroxykynurenine. OC formulation moderated biomarker associations in this cohort, with higher progestational and androgenic activity linked to a more proinflammatory profile and greater KP activation with more prior concussions. The results highlight OC use as a potential moderator of the cumulative psychological/immunological effects of repeat concussion in female athletes that should be considered when personalizing treatment for individuals with multiple injuries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.